HAVCR2 and hepatocellular carcinoma: Likewise, miR-181b can enhance matrix metallopeptidases (MMP) 2 and MMP9 activity and promoted growth, clonogenic survival, migration and invasion of hepatocellular carcinoma (HCC) cells by modulating a tumor suppressor, the tissue inhibitor of metalloprotease 3 (TIM3).